Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage

Pediatric Transplantation

Volumn 4, Issue 3, 2000, Pages 211-214

  Kayihan, Nilüfer ^a   Nennesmo, Inger ^a   Ericzon, Bo Göran ^a   Németh, Antal ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute fulminant liver failure; Cyclosporin A; Mitochondrial disease; Orthotopic liver transplant; Valproic acid

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METOPROLOL; NIFEDIPINE; OKT 3; PREDNISOLONE; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPILEPSY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER TRANSPLANTATION; MUSCLE BIOPSY; NEUROLOGIC DISEASE; SCHOOL CHILD;

ADOLESCENT; ANTICONVULSANTS; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; ELECTROENCEPHALOGRAPHY; EPILEPSY; FATAL OUTCOME; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; RISK FACTORS; VALPROIC ACID;

EID: 0033930459     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2000.00115.x     Document Type: Article

References (28)

1. TULINIUS MH, HOLME E, KRISTIANSSON B, LARSSON N-G, OLDFORS A. Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations. J Pediatr 1991: 119: 242-250.
2. TREEM WR, SOKOL RJ. Disorders of the mitochondria. Sem Liv Dis 1998: 18: 237-253.
3. GONÇALVES I, HERMANS D, CHRETIEN D, et al. Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 1995: 23: 290-294.
4. MAZZELLA M, CERONE R, BONACCI W, et al. Severe complex I deficiency in a case of neonatal-onset lactic acidosis and fatal liver failure. Acta Paediatr 1997: 86: 326-329.
5. DREIFUSS FE, SANTILL N, LANGER DH, SWEENEY KP, MOLINE BA, MENANDER KB. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987: 37: 379-385.
6. DREIFUSS FE, LANGER DH, MOLINE KA, MAXWELL JE. Valproic acid hepatic fatalities. Neurology 1989: 39 (Suppl. 2): 201-207.
7. COTARIU D, ZAIDMAN JL. Valproic acid and the liver. II US experience since 1984. Clin Chem 1988: 34: 890-897.
8. POWELL-JACKSON PR, TREDGER JM, WlLLIAMS R. Hepatotoxicity to sodium valproate: a review. Gut 1984: 25: 673-681.
9. GRAM L, DRACHMANN BENTSEN K. Valproate: an updated review. Acta Neurol Scand 1985: 72: 129-139.
10. WILLMORE LJ, TRIGGS WJ, PELLOCK JM. Valproate toxicity: risk-screening strategics. J Child Neurol 1991: 6: 3-6.
11. NARKEWICZ MR, SOKOL RJ, BECKWITH B, SONDHEIMER J, SILVERMAN A. Liver involvement in Alper's disease. J Pediatr 1991: 119: 260-267.
12. HUTTENLOCHER PR, SOLITARE GB, ADAMS G. Infantile diffuse cerebral degeneration with hepatic cirrhosis. Arch Neurol 1976: 33: 186-192.
13. BICKNESE AR, MAY W, HICKEY WF, DODSON WE. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 1992: 32: 767-775.
14. MUNNICH A, RÖTIG A, CHRETIEN D, et al. Clinical presentation of mitochondrial disorders in childhood. J Inner Metab Dis 1996: 19: 521-527.
15. GOTTRAND F, LARGILLIÉRE C, FARRIAUX J-P. Cyclosporine neurotoxicity. New Engl J Med 1991: 324: 1744-1745.
16. ADAMS DH, GUNSON B, HONIGSBERGER L, et al. Neurological complications following liver transplantation. Lancet 1987: 1: 949-951.
17. DEIERHOI MH, KALAYOGLU M, SOLLINGER HW, BELZER FO. Cyclosporine neurotoxicity in liver transplant recipient: report of three cases. Transplant Proc 1988: 20: 116-118.
18. BOHLIN A-B, BERG U, ENGLUND M, et al. Central nervous system complications in children treated with ciclosporin after renal transplantation. Child Nephrol Urol 1990: 10: 225-230.
19. POLSSON RJ, POWELL-JACKSON PR, WILLIAMS R. Convulsions associated with cyclosporin A in transplant recipients. BMJ 1985: 290: 100.
20. LIND MJ, MCWILLIAM L, JIP J, SCARFFE JH, MORGENSTERN GR, CHANG J. Cyclosporin associated demyelination following allogeneic bone marrow transplantation. Hematol Oncol 1989: 7: 49-52.
21. RUBIN AM, KANG H. Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 1987: 37: 1072-1076.
22. LAVENSTEIN B, STEWART C, TINA LU. Cyclosporine-associated encephalopathy in childhood transplant patients. Transplant Proc 1988: 20 (Suppl. 3): 285-287.
23. VOGT DP, LEDERMAN RJ, CAREY WD, BROUGHAN TA. Neurologic complications of liver transplantation. Transplantation 1988: 45: 1057-1061.
24. BÖSMÜLLER C, STEURER W, KÖNIGSRAINER A, WILLEIT J, MARGREITER R. Increased risk of central nervous system toxicity in patients treated with ciclosporin and imipenem/cilastatin. Nephron 1991: 58: 362-364.
25. DE BRUIJN KM, KLOMPMAKER IJ, SLOOFF MJH, FOCKENS P, HILLEN PH. Cyclosporine neurotoxicity late after liver transplantation. Transplantation 1989: 47: 575-576.
26. LUCEY MR, KOLARS JC, MERION RM, CAMPBELL DA, ALDRICH M, WATKINS PB. Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet 1990: 335: 11-15.
27. BOON AP, ADAMS DH, CAREY MP, WILLIAMS A, MCMASTER P, ELIAS E. Cyclosporin-associated cerebral lesions in liver transplantation. Lancet 1988: 1: 1457.
28. THOMSON M, MCKIERNAN P, BUCKELS J, MAYER D, KELLY D. Exclusion of generalised mitchondrial cytopathy before liver transplant in fulminant hepatic failure. ESPGAN 29th Annual Meeting 1996: 90.